New hope for advanced lung cancer: experimental drug combo enters global trial
NCT ID NCT07459751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two experimental drugs, HLX43 and HLX07, alone or together, against a standard chemotherapy (docetaxel) in people with advanced squamous non-small cell lung cancer whose first treatment stopped working. About 706 adults worldwide will take part. The goal is to see if the new drugs help people live longer or slow cancer growth better than current options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.